INDV EBITDA Growth

Indivior Pharmaceuticals Inc · EBITDA Growth

INDV logo

INDV EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported55.52%
INDV TTM EBITDA YoY % (-203.24% → 55.52%)
High-resolution chart · PNG

INDV ebitda growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Indivior Pharmaceuticals Inc EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
55.516%
280.6452%
192.3077%
312.987%
370.1923%
16.25%
55.2239%
130.1961%
-352.1739%
366.6667%
245.6522%
-203.2389%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.